![Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial | Nature Medicine Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01829-9/MediaObjects/41591_2022_1829_Fig1_HTML.png)
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial | Nature Medicine
![Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges | British Journal of Cancer Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01881-9/MediaObjects/41416_2022_1881_Fig1_HTML.png)
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges | British Journal of Cancer
![Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d385e043-80a7-49f0-9d1b-9892ce035b03/gr1.jpg)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![COVID-19's Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis - Cancer Research Institute (CRI) COVID-19's Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis - Cancer Research Institute (CRI)](https://www.cancerresearch.org/CRI/Files/39/398f6961-d6e9-4273-bca2-e3df0e5ac974.jpg)
COVID-19's Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis - Cancer Research Institute (CRI)
![Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS - Annals of Oncology Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/34dc7eef-9c11-42dd-ba9d-668aa32ca1b2/gr1.jpg)
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS - Annals of Oncology
Pancreatic cancer clinical trial to test new approach to treatment | Garvan Institute of Medical Research
![Whole-genome and transcriptome analysis enhances precision cancer treatment options - Annals of Oncology Whole-genome and transcriptome analysis enhances precision cancer treatment options - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d95fb836-cbf9-40ca-a4b3-829930265c43/gr1.jpg)
Whole-genome and transcriptome analysis enhances precision cancer treatment options - Annals of Oncology
![Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/73f2df0d-0edd-4eba-a066-3225d572b5a7/gr1.jpg)